Global Regulatory Collaborations Aim to Speed Access to New Vaccines & Drugs
June 29, 2020
The need for treatments to combat the spread of COVID-19 is promoting greater cooperation among drug regulatory authorities around the world, with FDA officials communicating more frequently with their counterparts in Europe, Canada, Japan and other nations through established programs and agreements.